DOD funds $4.3M human trial on device to enhance sleepResearchers will use new technology and imaging to improve the brain's waste clearance, impaired by sleep disruption.
- UW Medicine: Bobbi Nodell - email@example.com, 206.543.7129
- UNC School of Medicine: Mark Derewicz - firstname.lastname@example.org, 919.923.0959
The U.S. Department of Defense is funding the first human trial of a device to speed up and enhance the natural system of brain cleansing that occurs when we sleep.
The trial will be conducted among 90 people at three trial sites – University of Washington School of Medicine, University of North Carolina, and a collaboration between Oregon Health & Science University and the Brain Electrophysiology Laboratory. Results are expected in spring.
Recent discoveries point to the importance of quality sleep for clearance of brain metabolic waste through the newly discovered brain glymphatic system.
Co-principal investigator Jeffrey Iliff, professor of psychiatry and behavioral sciences and neurology at the University of Washington School of Medicine, made the discovery of the glymphatic system with Maiken Nedergaard, a Danish neuroscientist.
Iliff said the biology is straightforward. Cerebral spinal fluid surrounds the brain, and as we sleep, fluid washes through brain cells and supports clearance of difference wastes.
Scientists think this glymphatic function is at the heart of the restorative power of sleep. Scientists think sleep problems disrupt the glymphatic system, thereby impairing cognition and potentially affecting long-term brain health.
“Improving glymphatic function, whether pharmacologically or by means of a device, could improve the cognitive effects of acute sleep deprivation and chronic sleep restriction,” said Iliff. “Our lab’s research over the past eight years on brain-waste clearance in animals has helped define glymphatic biology. Now we hope to see if we can use what we’ve learned to help people overcome poor or interrupted sleep and the brain dysfunction that follows.”
The scientists leading this effort are from the UW School of Medicine, the University of North Carolina-Chapel Hill School of Medicine, the Brain Electrophysiology Lab, Oregon Health & Science University, and Montana State University.
The Department of Defense is funding this three-year, $4.3-million project, with the ultimate goal of helping service members overcome acute sleep deprivation and chronic sleep restriction.
“If this works, it would have major implications for service members and potentially anyone with diagnosed sleep dysfunction. It could also have implications for people with other neurological conditions, such as traumatic brain injury, Alzheimer’s disease, and other dementias,” said co-principal investigator Dawn Kernagis, assistant professor of neurosurgery at UNC-Chapel Hill School of Medicine
This project, titled “Augmented Neurophysiology of Sleep and Performance Readiness,” is part of the Medical Technology Enterprise Consortium, a collaboration between industry and academia to facilitate research and development activities, in cooperation with the U.S. Army Medical Research and Development Command and other Department of Defense agencies in the biomedical sciences to protect, treat, and optimize the health and performance of military personnel.
The proposed technology for improving glymphatic function is called Augmented Neural Oscillation Driver or ‘AugNOD’, an easily-to-use, wireless, combined electroencephalography (EEG)/transcranial electrical stimulation headband that can be applied before sleep to monitor and improve slow wave sleep and glymphatic clearance. Project co-principal investigator Don Tucker, professor emeritus at the University of Oregon and BEL CEO, created the technology.
The research team has also developed and validated an imaging and analysis system, including the use of magnetic resonance imaging to measure glymphatic exchange of fluids when individuals are given an intravenous mixture containing contrasting agents. The new study will validate novel imaging approaches developed at the UW School of Medicine that do not require contrast agents.
Through complete modeling conducted at the University of Montana, the team will also be able to capture long-range fluid transport and diffusion in the brain, as well as changes in brain blood vessel pressure. Both are closely linked to glymphatic pathway function.
“Beyond evaluating potential technology for improving glymphatic function, the resulting imaging and modeling approaches that will be validated in this study could be incredibly impactful for the neuroscience and neurological research fields given the limited options for studying a potentially critical system for short and long-term brain health,” Kernagis said.
For details about UW Medicine, please visit http://uwmedicine.org/about.